Comparing MIB-1 and S-phase Fraction in Breast Cancer
Author Information
Author(s): PA Ellis, A Makris, SA Burton, J Titley, MG Ormerod, J Salter, TJ Powles, IE Smith, M Dowsett
Primary Institution: Royal Marsden NHS Trust; Institute of Cancer Research
Hypothesis
The study aims to compare the usefulness of MIB-1 with S-phase fraction (SPF) as a measure of proliferation in breast cancer.
Conclusion
MIB-1 immunostaining is an effective method for assessing proliferation in human breast carcinomas.
Supporting Evidence
- MIB-1 staining showed a median score of 9% and SPF a median of 11.1%.
- A close correlation was found between MIB-1 score and SPF (rho = 0.59, P < 0.0001).
- The median MIB-1 score was significantly higher in aneuploid tumours compared to diploid tumours.
Takeaway
This study looked at how well a new test called MIB-1 works compared to a standard test for measuring how fast breast cancer cells are growing.
Methodology
The study involved staining tissue samples with MIB-1 and measuring S-phase fraction using flow cytometry.
Limitations
The correlation between MIB-1 and SPF was only significant in aneuploid tumours, and the study may not represent all breast cancer types.
Participant Demographics
75 post-menopausal patients with operable breast cancer, median ages 56 and 68 years for treatment and no treatment groups respectively.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI 0.48 - 0.76
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website